Prolonged infusion of dexmedetomidine for sedation following tracheal resection

Paediatric Anaesthesia

Volumn 15, Issue 7, 2005, Pages 616-620

  Hammer, Gregory B ^a,b   Philip, Bridget M ^a   Schroeder, Alan R ^a   Rosen, Frederick S ^a   Koltai, Peter J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alpha 2 adrenergic agonists; Anxiolysis; Dexmedetomidine; Tracheal resection

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; FENTANYL; ISOFLURANE; LORAZEPAM; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE DERIVATIVE; PROPOFOL; REMIFENTANIL; ROCURONIUM;

ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DRUG EFFICACY; DRUG INFUSION; FOOD AND DRUG ADMINISTRATION; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEDATION; SLEEP; SUBGLOTTIC STENOSIS; TRACHEA RECONSTRUCTION; TRACHEA RESECTION; TRANQUILIZING ACTIVITY;

ANESTHESIA; CHILD; CONSCIOUS SEDATION; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; LARYNGOSCOPY; MALE; RESPIRATION, ARTIFICIAL; TRACHEA; TRACHEAL STENOSIS;

EID: 21444437093     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2005.01656.x     Document Type: Article

References (24)

1. Wright CD, Graham BB, Grillo HC et al. Pediatric tracheal surgery. Ann Thorac Surg 2002; 74: 308-314.
2. Rothschild MA, Cotcamp D, Cotton RT. Postoperative medical management in single-stage laryngotracheoplasty. Arch Otolaryngol Head Neck Surg 1995; 12: 1175-1179.
3. Jacobs BR, Salman BA, Cotton RT et al. Postoperative management of children after single-stage laryngotracheal reconstruction. Crit Care Med 2001; 29: 164-168.
4. Rowe RW, Betts J, Free E. Perioperative management for laryngotracheal reconstruction. Anesth Analg 1991; 73: 483-486.
5. Segredo V, Caldwell JE, Matthay MA et al. Perisitent paralysis in critically ill patients after long term administration of vecuronium. N Engl J Med 1992; 327: 524-528.
6. Brandom B, Yellon RF, Lloyd ME et al. Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit. Anesth Analg 1997; 84: 307-314.
7. Young CC, Prielipp RC. Benzodiazepines in the intensive care unit. Crit Care Clin 2001; 17: 843-862.
8. Hall RI, Sandham D, Cardinal P et al. Propofol vs. midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001; 119: 1151-1159.
9. Parke TJ, Stevens JE, Rice ASC et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616.
10. AstraZeneca Pharmaceuticals LP. DIPRIVAN ®1% (propofol) Injectable Emulsion [Package Insert]. Wilmington, DE: Astra-Zeneca Pharmaceuticals LP, 2001.
11. Shelly MP, Sultan MA, Bodenham A et al. Midazolam infusions in critically ill patients. Eur J Anaesthesiol 1991; 8: 21-27.
12. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. The Pharmacological Basis of Therapeutics. 9th ed. London: McGraw-Hill, 1996: 521-533.
13. Siddappa R, Fletcher JE, Heard AM et al. Methadone for prevention of opioid withdrawal in children. Paediatr Anaesth 2003; 13: 805-810.
14. Fonsark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med 1999; 27: 196-199.
15. Hayashi Y, Maze M. Alpha-2 adrenoceptor agonists and anesthesia. Br J Anaesth 1993; 71: 108-118.
16. Dyck JB, Maze M, Haack C et al. The pharmacokinetics and hemodynamic effects of intravenous and intramuscuiular dexmedetomidine hydrochloride in human volunteers. Anesthesiology 1993; 78: 813-820.
17. Hall JE, Uhrich TD, Barney JA et al. Sedative, amnestic, and analgesic prcperties of small-dose dexmedetomidine infusion. Anesth Analg 2000; 90: 699-705.
18. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propcfol-based sedation regimens. J Cardiothorac Vasc Anesth 2003; 17: 576-584.
19. Davies MF, Haimor F, Lighthall G et al. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg 2003; 96: 195-200.
20. Riker RR, Ramsay MAE, Prielipp R et al. Long-term dexmedetomidine infusions for ICU sedation: a pilot study. Anesthesiology 2001; 95: A383.
21. Shehabi Y, Ruettimann U, Adamson H et al. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004; 30: 2188-2196.
22. Deutch ES, Nadkarni VM. Clonidine prohylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg 1996; 122: 1234-1238.
23. Kosten TR, O'Connor PG. Current concepts: management of drug and alcohol withdrawal. NEJM 2003; 348: 1786-1795.
24. Jasinski DR, Johnson RE, Kocher TR. Clonidine in morphine withdrawal: differential effects on signs and symptoms. Arch Gen Psychiatry 1985; 42: 1063-1066.